|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| |
June 28, 2024
Frazier Healthcare Partners, a Seattle-based, healthcare-focused investment firm, announced that it has completed its acquisition of BioMatrix Holdings. BioMatrix, headquartered in Plantation, Florida, is a national provider of home-based infusion services with clinical expertise in neurological diseases, immunology deficiencies and transplants, as well as blood disorders. BioMatrix serves a diversified base of patients with over 2,500 physician-referral relationships across all 50 states. Frazier is partnering with Ted and Kathee Kramm, two industry executives in the home infusion market, to lead BioMatrix. Ted and Kathee began their careers as clinicians (pharmacist and nurse, respectively) and have scaled multiple infusion pharmacy businesses. Effective as of the closing, Ted will serve as chief executive officer and Kathee as president of BioMatrix. Cantor Fitzgerald and Goodwin Procter served as Frazier's financial advisor and legal counsel. Founded in 1991, Frazier Healthcare Partners invests across the U.S., Canada, and Europe.